Atrial fibrillation Trials in Somerset West, South Africa
Conditions / Atrial fibrillation / Somerset West, South Africa
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00496769 | A Phase III Study of Apixaban in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01674647 | Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion | COMPLETED | PHASE3 |
| NCT00526136 | Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study | COMPLETED | PHASE2 |
| NCT00938730 | A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation | COMPLETED | PHASE2 |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT00281554 | Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |